Lilly profit beats forecast
April 24 (Reuters) - Eli Lilly and Co on Wednesday reported higher-than-expected first-quarter earnings, helped by sales of its treatments for diabetes, depression and lung cancer.
The company said it had net income of $1.55 billion, or $1.42 per share. That compared with $1.01 billion, or 91 cents per share, in the year-earlier period.
- Protesters fell Lenin statue, tell Ukraine's president 'you're next'
- Four dead in apparent Connecticut murder-suicide
- Singer Susan Boyle reveals she has Asperger's syndrome: paper
- South Korea expands air defense zone to partially overlap China's |
- Dynasty's Congress party punished in Indian state elections